Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOE,Apolipoprotein E,Inverse variance weighted,14,1.09 [1.05-1.13],6.3145564100724e-06,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NUDT5,ADP-sugar pyrophosphatase,Wald ratio,1,1.99 [1.43-2.78],4.73380004936446e-05,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACE,Angiotensin-converting enzyme,Inverse variance weighted,14,1.09 [1.04-1.14],0.000140597508594143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INHBB,Inhibin beta B chain,Inverse variance weighted,6,1.1 [1.04-1.16],0.00027681799567521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,7,0.9 [0.85-0.96],0.000493247838638414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RBKS,Ribokinase,Inverse variance weighted,5,0.9 [0.85-0.96],0.000523398099849861,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NCAN,Neurocan core protein,Inverse variance weighted,4,0.8 [0.7-0.91],0.000553841974158371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLIT2,Slit homolog 2 protein,Inverse variance weighted,2,1.57 [1.21-2.02],0.00061883654824196,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,10,1.08 [1.03-1.12],0.000673814688083925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,8,1.1 [1.04-1.17],0.0010872983149801,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,10,0.92 [0.87-0.97],0.00159236750646868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRM,Receptor-type tyrosine-protein phosphatase mu,Inverse variance weighted,2,0.68 [0.53-0.87],0.00193962531401788,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD300A,CMRF35-like molecule 8,Inverse variance weighted,3,1.1 [1.03-1.17],0.00224744785948064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TDRKH,Tudor and KH domain-containing protein,Inverse variance weighted,5,0.76 [0.63-0.91],0.00252338923998507,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MME,Neprilysin,Inverse variance weighted,3,1.39 [1.12-1.72],0.00257694563606139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SUOX,"Sulfite oxidase, mitochondrial",Wald ratio,1,0.53 [0.35-0.8],0.00260868755688505,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.79 [0.68-0.92],0.002764310924528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC3B,Tetranectin,Inverse variance weighted,6,1.12 [1.04-1.22],0.00333938563947727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VSNL1,Visinin-like protein 1,Inverse variance weighted,7,1.14 [1.04-1.24],0.00370577970670847,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSS,Cathepsin S,Inverse variance weighted,14,1.06 [1.02-1.11],0.00434339073398834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,12,0.9 [0.83-0.97],0.00462672499668305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MYOC,Myocilin,Inverse variance weighted,9,0.92 [0.87-0.98],0.00474243324533297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SHBG,Sex hormone-binding globulin,Inverse variance weighted,6,0.91 [0.86-0.97],0.00483759620750543,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLC27A4,Long-chain fatty acid transport protein 4,Wald ratio,1,1.68 [1.17-2.4],0.00487053870923524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD302,CD302 antigen,Inverse variance weighted,6,0.9 [0.84-0.97],0.00557294974252805,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,1.56 [1.14-2.13],0.0057568606966695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,3,1.15 [1.04-1.27],0.00655096946214985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NUCB2,Nucleobindin-2,Inverse variance weighted,13,0.93 [0.88-0.98],0.00823181156346345,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD59,CD59 glycoprotein,Inverse variance weighted,5,1.11 [1.03-1.19],0.00895113248308602,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MEP1A,Meprin A subunit alpha,Inverse variance weighted,7,0.9 [0.82-0.97],0.0101128629129854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD164,Sialomucin core protein 24,Inverse variance weighted,3,1.19 [1.04-1.36],0.0108797474995767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RSPO3,R-spondin-3,Inverse variance weighted,3,0.87 [0.78-0.97],0.0109272729743279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,5,1.09 [1.02-1.17],0.0113219716761855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL5RA,Interleukin-5 receptor subunit alpha,Inverse variance weighted,13,1.05 [1.01-1.09],0.0113977633686288,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENTR1,Endosome-associated-trafficking regulator 1,Inverse variance weighted,5,1.13 [1.03-1.24],0.0118876936760712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ERBB3,Receptor tyrosine-protein kinase erbB-3,Inverse variance weighted,3,1.29 [1.06-1.58],0.0120392394751276,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DSG2,Desmoglein-2,Inverse variance weighted,6,0.91 [0.84-0.98],0.0127231744569402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,5,1.13 [1.03-1.24],0.0130728215621706,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DLK1,Protein delta homolog 1,Inverse variance weighted,14,0.95 [0.92-0.99],0.0132143783128737,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GAL,Galanin peptides,Wald ratio,1,0.56 [0.35-0.89],0.0133478729139558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MAN2B2,Epididymis-specific alpha-mannosidase,Inverse variance weighted,7,0.95 [0.91-0.99],0.0135329981040464,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,0.92 [0.86-0.98],0.0140266544043922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,16,1.05 [1.01-1.1],0.0157548181342482,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,4,0.85 [0.74-0.97],0.0166075166304496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,5,1.1 [1.02-1.19],0.0166633701281804,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,0.68 [0.5-0.93],0.0173564429185138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.9 [0.83-0.98],0.0174525896760977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANPEP,Aminopeptidase N,Inverse variance weighted,11,1.06 [1.01-1.12],0.0178693707840239,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PI3,Elafin,Inverse variance weighted,7,1.06 [1.01-1.11],0.0181685127309784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EFNA4,Ephrin-A4,Wald ratio,1,1.58 [1.08-2.32],0.018626406051122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.24 [1.03-1.48],0.0196038364685242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,8,1.07 [1.01-1.13],0.0216915933024203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AKR1C4,Aldo-keto reductase family 1 member C4,Wald ratio,1,0.65 [0.45-0.94],0.0217889509148207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,1.06 [1.01-1.11],0.0231102132450787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,10,0.94 [0.89-0.99],0.023507577706359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FSHB,Follitropin subunit beta,Inverse variance weighted,2,1.23 [1.03-1.46],0.025104219428075,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLAT,Tissue-type plasminogen activator,Wald ratio,1,1.29 [1.03-1.61],0.025218486732851,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CFI,Complement factor I,Inverse variance weighted,5,0.91 [0.84-0.99],0.0253428479879705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BSG,Basigin,Wald ratio,1,1.17 [1.02-1.34],0.0265392803139842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,6,1.08 [1.01-1.15],0.0267030185102533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.61 [0.4-0.95],0.0274295416627208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TMPRSS15,Enteropeptidase,Inverse variance weighted,3,1.17 [1.02-1.35],0.0302930797390701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,3,0.87 [0.77-0.99],0.031177008967043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,3,1.13 [1.01-1.26],0.031351528785854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,13,0.95 [0.9-1],0.0319707432470527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,S100A14,Protein S100-A14,Wald ratio,1,0.62 [0.4-0.96],0.0323975932115123,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AFM,Afamin,Inverse variance weighted,3,1.23 [1.02-1.5],0.0343662269623864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NOS3,"Nitric oxide synthase, endothelial",Wald ratio,1,1.55 [1.03-2.32],0.0357259538132132,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GZMA,Granzyme A,Inverse variance weighted,3,1.27 [1.02-1.58],0.0358798278570478,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,0.92 [0.85-1],0.0377796127807742,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,14,0.96 [0.93-1],0.0393588803469179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPA33,Cell surface A33 antigen,Inverse variance weighted,3,0.9 [0.81-1],0.0398218374372573,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.65 [0.42-0.98],0.0402714956619916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGFBP3,Fibroblast growth factor-binding protein 3,Inverse variance weighted,8,0.89 [0.8-1],0.0415502088998373,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD109,CD109 antigen,Inverse variance weighted,23,0.97 [0.94-1],0.042451494792413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,0.84 [0.71-0.99],0.0425786440583253,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,4,0.92 [0.85-1],0.0434854842399992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,Wald ratio,1,0.71 [0.51-0.99],0.0458758248401626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANXA2,Annexin A2,Inverse variance weighted,11,0.91 [0.83-1],0.0474074192494884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL1R2,Interleukin-1 receptor type 2,Inverse variance weighted,9,1.05 [1-1.11],0.0487006591999326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TCN2,Transcobalamin-2,Inverse variance weighted,18,0.97 [0.94-1],0.0490320139318189,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,10,0.93 [0.86-1],0.0490507773710594,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.08 [1-1.18],0.0507060313790281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,15,1.05 [1-1.1],0.0514913910718698,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SELPLG,P-selectin glycoprotein ligand 1,Inverse variance weighted,2,0.8 [0.64-1],0.0523475847828221,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.18 [1-1.4],0.0524031639470558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GUSB,Beta-glucuronidase,Wald ratio,1,1.16 [1-1.36],0.053416440380692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.51 [0.99-2.29],0.0544377768334366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LCN15,Lipocalin-15,Inverse variance weighted,6,1.05 [1-1.11],0.0546304887926468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,THOP1,Thimet oligopeptidase,Inverse variance weighted,4,0.92 [0.85-1],0.0551852506095424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLXDC2,Plexin domain-containing protein 2,Inverse variance weighted,4,1.17 [1-1.38],0.0564135835937805,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.8 [0.64-1.01],0.0564248042546417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCAMP3,Secretory carrier-associated membrane protein 3,Wald ratio,1,0.78 [0.6-1.01],0.0587787925583992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,2,1.25 [0.99-1.59],0.0600554576104529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SFRP4,Secreted frizzled-related protein 4,Inverse variance weighted,3,1.09 [1-1.18],0.0604771103017016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,20,1.03 [1-1.07],0.060730909448231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,20,0.97 [0.94-1],0.0659566602512311,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,10,0.96 [0.91-1],0.0660311492796555,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PGA4,Pepsin A-4,Inverse variance weighted,2,1.34 [0.98-1.82],0.0666179602049456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FUOM,Fucose mutarotase,Wald ratio,1,0.74 [0.54-1.02],0.068236844063794,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,9,1.07 [1-1.14],0.068649151485872,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,2,0.9 [0.8-1.01],0.0695418104138672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,4,0.9 [0.8-1.01],0.073966227496986,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CALB1,Calbindin,Wald ratio,1,0.71 [0.49-1.03],0.0745961107999481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COMP,Cartilage oligomeric matrix protein,Inverse variance weighted,5,1.08 [0.99-1.17],0.075346841424736,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,1.12 [0.99-1.27],0.075350262819204,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,20,1.02 [1-1.05],0.0765902942643992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,10,1.04 [1-1.09],0.0767641633601991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANG,Angiogenin,Inverse variance weighted,14,0.96 [0.92-1],0.0790667305359166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MB,Myoglobin,Wald ratio,1,1.6 [0.95-2.7],0.0791434164538045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GSTA1,Glutathione S-transferase A1,Inverse variance weighted,3,1.06 [0.99-1.12],0.0804723560517643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGALS1,Galectin-1,Inverse variance weighted,4,0.94 [0.88-1.01],0.0810124198956229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GSTA3,Glutathione S-transferase A3,Inverse variance weighted,3,1.05 [0.99-1.12],0.081361901568377,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,YES1,Tyrosine-protein kinase Yes,Inverse variance weighted,2,1.21 [0.98-1.49],0.0814870361556473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Inverse variance weighted,7,0.95 [0.9-1.01],0.0820389036601873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD46,Membrane cofactor protein,Wald ratio,1,0.83 [0.66-1.02],0.0821477553150461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BCHE,Cholinesterase,Inverse variance weighted,14,0.95 [0.91-1.01],0.08251174403541,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HNMT,Histamine N-methyltransferase,Inverse variance weighted,12,0.97 [0.94-1],0.0829032476829926,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,13,0.95 [0.89-1.01],0.0829352419034482,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,5,0.91 [0.83-1.01],0.0833053524082252,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,1.2 [0.98-1.47],0.0844106257176905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLSTN2,Calsyntenin-2,Inverse variance weighted,15,0.96 [0.92-1.01],0.086218938224224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HMOX1,Heme oxygenase 1,Wald ratio,1,0.8 [0.61-1.03],0.0869506557363371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,32,1.02 [1-1.04],0.0875093655440612,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAYN,Layilin,Inverse variance weighted,12,0.95 [0.9-1.01],0.0880079179910654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TYMP,Thymidine phosphorylase,Inverse variance weighted,4,1.08 [0.99-1.17],0.0885530926621876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINI1,Neuroserpin,Inverse variance weighted,12,1.05 [0.99-1.1],0.0888942324684243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DPP7,Dipeptidyl peptidase 2,Wald ratio,1,0.83 [0.66-1.03],0.0903805379780361,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,2,1.23 [0.97-1.56],0.0911048258047591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,2,1.07 [0.99-1.16],0.091679155774651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL22,C-C motif chemokine 22,Inverse variance weighted,4,0.91 [0.81-1.02],0.0917288110416473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACY1,Aminoacylase-1,Wald ratio,1,1.15 [0.98-1.35],0.0920649573305027,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,4,0.94 [0.88-1.01],0.0930849560669766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPE,Carboxypeptidase E,Inverse variance weighted,8,0.94 [0.87-1.01],0.0932654393514148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,5,1.11 [0.98-1.26],0.0942435771901795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",Wald ratio,1,1.31 [0.95-1.79],0.0948557681032622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,5,1.05 [0.99-1.11],0.0952490060487045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CNTN2,Contactin-2,Inverse variance weighted,12,0.97 [0.94-1.01],0.096185190441744,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ICAM4,Intercellular adhesion molecule 4,Wald ratio,1,1.16 [0.97-1.37],0.0967265984204665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINB8,Serpin B8,Inverse variance weighted,14,0.98 [0.96-1],0.0980038906113633,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,8,1.07 [0.99-1.17],0.0981476695244464,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.42 [0.94-2.15],0.100114963510672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,13,0.96 [0.92-1.01],0.101097018992825,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Wald ratio,1,0.73 [0.51-1.06],0.101686316343002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.15 [0.97-1.35],0.10311111584687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLA2G1B,Phospholipase A2,Wald ratio,1,0.75 [0.53-1.06],0.104538804894769,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,Inverse variance weighted,7,0.94 [0.87-1.01],0.104901757268625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC9,Sialic acid-binding Ig-like lectin 9,Inverse variance weighted,8,0.96 [0.91-1.01],0.105244058289114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FETUB,Fetuin-B,Inverse variance weighted,6,1.06 [0.99-1.15],0.105928530233931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NME3,Nucleoside diphosphate kinase 3,Inverse variance weighted,4,1.12 [0.98-1.28],0.106023090473614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GHRL,Appetite-regulating hormone,Inverse variance weighted,2,0.9 [0.8-1.02],0.106849198752308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.07 [0.99-1.16],0.109650733783819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,19,1.02 [0.99-1.05],0.111583328487094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,15,1.05 [0.99-1.1],0.11220661788216,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.06 [0.99-1.13],0.113806157062781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,2,1.08 [0.98-1.19],0.116143410477739,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,8,1.04 [0.99-1.09],0.116509508260543,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,7,0.95 [0.88-1.01],0.117082159552692,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD248,Endosialin,Wald ratio,1,1.21 [0.95-1.53],0.120429961281108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,6,0.93 [0.84-1.02],0.120433058926759,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPA2,Carboxypeptidase A2,Inverse variance weighted,11,0.97 [0.92-1.01],0.120830719192142,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,1.11 [0.97-1.28],0.124319391528005,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,7,1.17 [0.96-1.43],0.124754733318623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIAE,Sialate O-acetylesterase,Wald ratio,1,1.07 [0.98-1.17],0.126552166924687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Inverse variance weighted,12,1.05 [0.99-1.13],0.126741536332163,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFF2,Trefoil factor 2,Inverse variance weighted,3,0.91 [0.8-1.03],0.127435066743393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,1.04 [0.99-1.08],0.131085150583319,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,15,0.96 [0.91-1.01],0.131557935421927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,17,0.97 [0.93-1.01],0.131928300687049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,14,1.04 [0.99-1.1],0.134072978121519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,9,1.04 [0.99-1.1],0.134317184797305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRSS8,Prostasin,Inverse variance weighted,4,1.16 [0.95-1.42],0.136707982040205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRSS27,Serine protease 27,Inverse variance weighted,5,0.92 [0.82-1.03],0.136876373780685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEP43,Centrosomal protein 43,Inverse variance weighted,2,1.26 [0.93-1.7],0.138598486842789,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,22,1.02 [0.99-1.05],0.138966866417917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,15,0.96 [0.91-1.01],0.139672731756665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,5,1.07 [0.98-1.17],0.140904943705631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NOMO1,Nodal modulator 1,Wald ratio,1,1.15 [0.95-1.39],0.142591220471763,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.1 [0.97-1.24],0.145797724746963,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,2,1.08 [0.97-1.21],0.14666542907346,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,2,0.93 [0.85-1.03],0.151522858324043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,6,1.04 [0.98-1.1],0.151661371470078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL5,C-C motif chemokine 5,Inverse variance weighted,2,1.08 [0.97-1.21],0.155000883449324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,2,0.91 [0.79-1.04],0.159709738436991,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Wald ratio,1,0.9 [0.77-1.04],0.159998887820939,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AOC3,Membrane primary amine oxidase,Inverse variance weighted,13,0.96 [0.9-1.02],0.160805171495945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNC,Tenascin,Inverse variance weighted,7,1.05 [0.98-1.12],0.160979943823111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Wald ratio,1,0.83 [0.65-1.08],0.162220094110145,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,8,0.95 [0.89-1.02],0.162589845458395,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CR2,Complement receptor type 2,Inverse variance weighted,3,0.92 [0.81-1.04],0.162985658357776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDH3,Cadherin-3,Wald ratio,1,0.84 [0.65-1.08],0.165953994924479,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,2,0.77 [0.53-1.12],0.166824302709625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TLR1,Toll-like receptor 1,Inverse variance weighted,11,1.04 [0.98-1.09],0.16822704189263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,0.88 [0.74-1.05],0.169796208836782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,Inverse variance weighted,5,0.95 [0.89-1.02],0.170172762733734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.85 [0.67-1.07],0.171286251151678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRRT3,Proline-rich transmembrane protein 3,Wald ratio,1,1.12 [0.95-1.31],0.171619787082863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.08 [0.97-1.2],0.172884890290049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,10,0.96 [0.91-1.02],0.174308106719954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.08 [0.97-1.2],0.174486409201286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.21 [0.92-1.59],0.174757360179791,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,2,1.21 [0.92-1.59],0.175221086134909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,Inverse variance weighted,5,1.04 [0.98-1.1],0.175576927536064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,11,1.03 [0.99-1.07],0.176034916265488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,8,0.96 [0.9-1.02],0.176786680132959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLK3,Prostate-specific antigen,Inverse variance weighted,2,1.22 [0.91-1.62],0.177256592117072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRNN,Cornulin,Inverse variance weighted,9,0.97 [0.93-1.01],0.182886914323819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IFNLR1,Interferon lambda receptor 1,Inverse variance weighted,4,0.86 [0.7-1.07],0.183497114911471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AHSG,Alpha-2-HS-glycoprotein,Inverse variance weighted,16,1.02 [0.99-1.05],0.185089460919684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,THBS4,Thrombospondin-4,Inverse variance weighted,7,1.04 [0.98-1.11],0.186932696001473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,5,1.03 [0.99-1.07],0.187456556560612,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.1 [0.95-1.26],0.189430850224903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ASAH1,Acid ceramidase,Inverse variance weighted,13,1.02 [0.99-1.06],0.189693391341637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SELE,E-selectin,Inverse variance weighted,2,1.14 [0.94-1.39],0.191690668278387,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GDF15,Growth/differentiation factor 15,Inverse variance weighted,10,0.95 [0.89-1.02],0.193351422571004,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,10,1.03 [0.99-1.07],0.193733669854172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MARCO,Macrophage receptor MARCO,Inverse variance weighted,7,1.08 [0.96-1.22],0.194231499808707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,6,0.97 [0.93-1.01],0.19475341175277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PXN,Paxillin,Inverse variance weighted,7,0.97 [0.93-1.02],0.197075307893306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OCLN,Occludin,Wald ratio,1,0.91 [0.8-1.05],0.198346940373143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHRDL2,Chordin-like protein 2,Inverse variance weighted,4,1.05 [0.97-1.14],0.198512549468065,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OPTC,Opticin,Inverse variance weighted,4,1.09 [0.96-1.24],0.198635885578878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.88 [0.72-1.07],0.199454478706667,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,7,0.95 [0.89-1.03],0.203409668790216,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXCL6,C-X-C motif chemokine 6,Inverse variance weighted,11,0.94 [0.85-1.04],0.204086574390886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.22 [0.89-1.68],0.206500115615641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,5,1.07 [0.97-1.18],0.206541347109318,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SRP14,Signal recognition particle 14 kDa protein,Wald ratio,1,1.29 [0.87-1.91],0.208690755641349,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL4,C-C motif chemokine 4,Inverse variance weighted,11,0.96 [0.9-1.02],0.209070243296524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,12,0.98 [0.95-1.01],0.210481167640508,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DMP1,Dentin matrix acidic phosphoprotein 1,Wald ratio,1,0.79 [0.54-1.14],0.211260368704019,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.85 [0.66-1.1],0.211459762369481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NFASC,Neurofascin,Inverse variance weighted,14,1.03 [0.98-1.07],0.211680907136716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,1.09 [0.95-1.26],0.212533369490096,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,12,1.03 [0.99-1.07],0.21277370479285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCN3,CCN family member 3,Inverse variance weighted,13,0.96 [0.9-1.02],0.212903365606402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TF,Serotransferrin,Inverse variance weighted,6,0.95 [0.89-1.03],0.213191584844309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FDX1,"Adrenodoxin, mitochondrial",Wald ratio,1,0.79 [0.54-1.15],0.215294999710158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSL,Cathepsin L1,Wald ratio,1,1.29 [0.86-1.93],0.217291467546195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DPY30,Protein dpy-30 homolog,Wald ratio,1,0.81 [0.58-1.13],0.217519454234425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,8,1.04 [0.98-1.1],0.217746438580536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,16,0.97 [0.93-1.02],0.218995966961685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GSN,Gelsolin,Inverse variance weighted,3,0.91 [0.78-1.06],0.219100736062568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,3,0.91 [0.78-1.06],0.219851318536384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DKK4,Dickkopf-related protein 4,Inverse variance weighted,3,0.95 [0.88-1.03],0.220999790430049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CES3,Carboxylesterase 3,Inverse variance weighted,4,1.06 [0.97-1.16],0.221899245848623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENO3,Beta-enolase,Wald ratio,1,1.15 [0.92-1.44],0.222118225867086,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,24,1.02 [0.99-1.05],0.222984980874669,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,15,1.03 [0.98-1.07],0.22304089482243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,5,1.03 [0.98-1.09],0.223961361858656,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,3,1.06 [0.97-1.16],0.226858650018577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NADK,NAD kinase,Inverse variance weighted,3,0.96 [0.9-1.03],0.231376823669827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MATN3,Matrilin-3,Inverse variance weighted,16,1.02 [0.99-1.06],0.231522554833505,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,5,0.96 [0.89-1.03],0.231806783487051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.11 [0.94-1.32],0.232760217998156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,1.19 [0.89-1.58],0.233064231689616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,17,1.03 [0.98-1.07],0.234024253146445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.79 [0.54-1.16],0.234102800426905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,1.02 [0.99-1.05],0.234461492614386,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SORD,Sorbitol dehydrogenase,Inverse variance weighted,2,0.93 [0.83-1.05],0.234740273396716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD83,CD83 antigen,Inverse variance weighted,5,1.09 [0.95-1.24],0.235646966557647,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ERP44,Endoplasmic reticulum resident protein 44,Wald ratio,1,0.78 [0.52-1.17],0.236265703890609,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,UMOD,Uromodulin,Inverse variance weighted,18,0.98 [0.95-1.01],0.236398632550943,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DKK1,Dickkopf-related protein 1,Inverse variance weighted,2,0.92 [0.79-1.06],0.23840681325122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GNPDA2,Glucosamine-6-phosphate isomerase 2,Inverse variance weighted,5,0.92 [0.8-1.06],0.238599100949938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,UPB1,Beta-ureidopropionase,Wald ratio,1,0.75 [0.47-1.21],0.238755848335947,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,Wald ratio,1,1.22 [0.88-1.7],0.238962432490611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDH6,Cadherin-6,Inverse variance weighted,16,1.02 [0.99-1.06],0.239520076206228,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KHK,Ketohexokinase,Inverse variance weighted,11,1.04 [0.97-1.11],0.240381027578441,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MEP1B,Meprin A subunit beta,Inverse variance weighted,21,1.01 [0.99-1.04],0.241187037681849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,3,1.09 [0.95-1.25],0.241548508150908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,11,0.97 [0.92-1.02],0.243999587440049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IDUA,Alpha-L-iduronidase,Inverse variance weighted,10,1.03 [0.98-1.08],0.244117601100646,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,1.11 [0.93-1.34],0.244996670598816,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,JAM2,Junctional adhesion molecule B,Wald ratio,1,0.78 [0.5-1.19],0.24500781362908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLAMF7,SLAM family member 7,Inverse variance weighted,12,0.98 [0.94-1.01],0.248010162307835,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,6,0.93 [0.82-1.05],0.250290800935858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.81 [0.57-1.16],0.250869172087985,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCS,Copper chaperone for superoxide dismutase,Inverse variance weighted,18,1.04 [0.98-1.1],0.253604084476234,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,4,0.95 [0.88-1.03],0.254177501142507,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MVK,Mevalonate kinase,Wald ratio,1,0.87 [0.68-1.11],0.254596606377151,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,Inverse variance weighted,5,1.04 [0.97-1.11],0.255250234628009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,6,0.94 [0.85-1.04],0.255540441235178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,5,0.93 [0.83-1.05],0.255643660357845,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,6,1.03 [0.98-1.08],0.256310419670162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,1.02 [0.98-1.07],0.258957182075612,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DTNB,Dystrobrevin beta,Wald ratio,1,1.29 [0.83-2.02],0.25963378888023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HEG1,Protein HEG homolog 1,Inverse variance weighted,3,1.08 [0.94-1.25],0.259878867338486,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,4,1.19 [0.88-1.6],0.260221171926278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VASN,Vasorin,Inverse variance weighted,8,1.02 [0.98-1.07],0.260721462567314,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.75 [0.45-1.24],0.262374485626814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PKD2,Polycystin-2,Inverse variance weighted,3,0.9 [0.75-1.08],0.262532123763009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MUC13,Mucin-13,Inverse variance weighted,9,0.96 [0.88-1.04],0.264759570962083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.13 [0.91-1.41],0.266501609911333,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PGF,Placenta growth factor,Inverse variance weighted,2,1.2 [0.87-1.67],0.267185902375868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,8,0.94 [0.84-1.05],0.267431149567249,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TOP2B,DNA topoisomerase 2-beta,Wald ratio,1,0.87 [0.68-1.11],0.269679210061348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,Inverse variance weighted,6,1.08 [0.94-1.24],0.270337029782998,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.97 [0.92-1.02],0.272125006307157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GM2A,Ganglioside GM2 activator,Inverse variance weighted,16,1.02 [0.99-1.05],0.272760130187689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,4,1.07 [0.95-1.2],0.274359064330348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,8,0.92 [0.79-1.07],0.274966065673824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPPB,Natriuretic peptides B,Wald ratio,1,0.94 [0.85-1.05],0.278285284071738,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,7,0.97 [0.92-1.03],0.278783349067139,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Wald ratio,1,1.29 [0.81-2.05],0.27903293865871,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GGH,Gamma-glutamyl hydrolase,Inverse variance weighted,16,0.98 [0.93-1.02],0.279330404505548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,6,0.95 [0.88-1.04],0.280060842133603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AKAP12,A-kinase anchor protein 12,Wald ratio,1,1.23 [0.84-1.8],0.28041448772082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCDH9,Protocadherin-9,Inverse variance weighted,11,1.03 [0.97-1.09],0.280605826768172,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SHMT1,"Serine hydroxymethyltransferase, cytosolic",Inverse variance weighted,20,0.98 [0.94-1.02],0.281677068316868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.1 [0.92-1.32],0.281758829883376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRSS2,Trypsin-2,Inverse variance weighted,3,0.93 [0.83-1.06],0.285405821530684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,8,0.98 [0.94-1.02],0.285810215179337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SEMA3F,Semaphorin-3F,Inverse variance weighted,3,1.11 [0.92-1.33],0.287303246567013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGSF9,Protein turtle homolog A,Inverse variance weighted,4,1.08 [0.94-1.25],0.287517076611827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CX3CL1,Fractalkine,Inverse variance weighted,5,1.09 [0.93-1.29],0.288953179990701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,10,0.98 [0.94-1.02],0.28978548249505,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,3,1.12 [0.91-1.38],0.289830291820766,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCDH1,Protocadherin-1,Wald ratio,1,0.88 [0.69-1.12],0.290047109648976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FABP5,Fatty acid-binding protein 5,Wald ratio,1,0.91 [0.76-1.09],0.290375142858353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,7,0.9 [0.74-1.09],0.291888311530197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DPT,Dermatopontin,Inverse variance weighted,16,0.97 [0.92-1.03],0.292452703005771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,3,1.03 [0.98-1.09],0.293747327080973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,F2R,Proteinase-activated receptor 1,Inverse variance weighted,2,1.08 [0.93-1.26],0.295346428455166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NTF3,Neurotrophin-3,Inverse variance weighted,6,1.05 [0.96-1.16],0.295710822752114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTRC,Chymotrypsin-C,Inverse variance weighted,10,1.03 [0.98-1.08],0.296084298037629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FBLN2,Fibulin-2,Inverse variance weighted,3,0.96 [0.88-1.04],0.297410182113,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLMP,CXADR-like membrane protein,Inverse variance weighted,9,1.04 [0.97-1.12],0.298209645193205,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,2,0.85 [0.63-1.16],0.300249040807816,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DDT,D-dopachrome decarboxylase,Inverse variance weighted,2,0.95 [0.87-1.04],0.301480499247942,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.13 [0.89-1.43],0.302778037919495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,4,0.94 [0.85-1.05],0.3045617988977,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,13,0.98 [0.96-1.01],0.305758372384996,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOA2,Apolipoprotein A-II,Wald ratio,1,0.86 [0.64-1.15],0.306483638905149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SETMAR,Histone-lysine N-methyltransferase SETMAR,Inverse variance weighted,3,1.04 [0.96-1.13],0.309482434858734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GHR,Growth hormone receptor,Inverse variance weighted,15,1.03 [0.98-1.08],0.309708405182763,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,Inverse variance weighted,4,0.91 [0.76-1.09],0.309924956618683,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PALM,Paralemmin-1,Inverse variance weighted,5,1.05 [0.96-1.15],0.310265931197027,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MANSC1,MANSC domain-containing protein 1,Wald ratio,1,1.22 [0.83-1.79],0.312185469646455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP12,Macrophage metalloelastase,Inverse variance weighted,15,0.98 [0.94-1.02],0.313882347926436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IPCEF1,Interactor protein for cytohesin exchange factors 1,Wald ratio,1,1.13 [0.89-1.44],0.313987240262089,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AREG,Amphiregulin,Inverse variance weighted,3,0.95 [0.85-1.05],0.314967669037063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEMIP2,Cell surface hyaluronidase,Inverse variance weighted,4,0.95 [0.86-1.05],0.316359279399972,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.13 [0.89-1.42],0.317599329289238,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TLR3,Toll-like receptor 3,Inverse variance weighted,18,1.02 [0.98-1.06],0.319659030310424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PDCD1,Programmed cell death protein 1,Inverse variance weighted,2,1.07 [0.94-1.23],0.32134976868571,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MDK,Midkine,Inverse variance weighted,3,0.92 [0.79-1.08],0.321452809006202,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PODXL2,Podocalyxin-like protein 2,Wald ratio,1,1.06 [0.94-1.2],0.32479290046825,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,Wald ratio,1,1.09 [0.92-1.31],0.325010516476735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCN4,CCN family member 4,Inverse variance weighted,14,0.98 [0.93-1.02],0.327122384653074,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSE,Cathepsin E,Inverse variance weighted,7,1.03 [0.97-1.11],0.327826331522305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FLT3LG,Fms-related tyrosine kinase 3 ligand,Wald ratio,1,0.79 [0.49-1.27],0.328168441572716,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSME1,Proteasome activator complex subunit 1,Wald ratio,1,0.89 [0.71-1.12],0.328213130205519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSME2,Proteasome activator complex subunit 2,Wald ratio,1,0.9 [0.73-1.11],0.328213130205519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RBP2,Retinol-binding protein 2,Wald ratio,1,0.87 [0.65-1.16],0.331753616543055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSD,Cathepsin D,Inverse variance weighted,7,1.05 [0.95-1.15],0.332990357780078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TREH,Trehalase,Inverse variance weighted,16,1.01 [0.99-1.03],0.333024568772705,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGALS4,Galectin-4,Inverse variance weighted,3,0.93 [0.8-1.08],0.333372919538696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.84 [0.6-1.19],0.334269226231896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,10,0.97 [0.91-1.03],0.336106384113414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GBP1,Guanylate-binding protein 1,Inverse variance weighted,8,0.97 [0.91-1.03],0.337425315688779,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,10,0.96 [0.87-1.05],0.340592280856049,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,7,0.97 [0.92-1.03],0.340750915631665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MEGF10,Multiple epidermal growth factor-like domains protein 10,Inverse variance weighted,14,1.03 [0.97-1.1],0.341529093911267,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,13,1.05 [0.95-1.15],0.342893089691118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,10,0.98 [0.95-1.02],0.343872298906917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CFH,Complement factor H,Inverse variance weighted,6,1.03 [0.97-1.08],0.344692123852384,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CST3,Cystatin-C,Inverse variance weighted,7,1.04 [0.96-1.14],0.345495407010612,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SELL,L-selectin,Inverse variance weighted,8,0.97 [0.9-1.04],0.349644809536109,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BAG3,BAG family molecular chaperone regulator 3,Inverse variance weighted,2,0.89 [0.71-1.13],0.350086725135746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFF3,Trefoil factor 3,Inverse variance weighted,3,1.08 [0.92-1.26],0.351778070400329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.98 [0.93-1.02],0.351825996227076,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,12,0.98 [0.95-1.02],0.352575643753967,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CNTN5,Contactin-5,Inverse variance weighted,19,1.02 [0.98-1.06],0.354039048941043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VNN2,Vascular non-inflammatory molecule 2,Inverse variance weighted,15,0.97 [0.9-1.04],0.354104165209682,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TCTN3,Tectonic-3,Inverse variance weighted,17,1.01 [0.98-1.05],0.356424004557335,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NOTCH3,Neurogenic locus notch homolog protein 3,Wald ratio,1,0.89 [0.69-1.14],0.356540456434288,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,5,1.03 [0.97-1.09],0.356788209824856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNASE4,Ribonuclease 4,Inverse variance weighted,8,0.97 [0.92-1.03],0.358028232668819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,3,0.94 [0.84-1.07],0.359205783651026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,9,1.02 [0.98-1.06],0.360391233108278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C1RL,Complement C1r subcomponent-like protein,Wald ratio,1,1.24 [0.78-1.95],0.360484799471683,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRISP3,Cysteine-rich secretory protein 3,Inverse variance weighted,24,1.02 [0.98-1.05],0.361923130342632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLAMF8,SLAM family member 8,Inverse variance weighted,14,0.99 [0.97-1.01],0.363219741351149,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,5,0.96 [0.89-1.05],0.365290870562774,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,4,0.97 [0.92-1.03],0.365615058142046,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Wald ratio,1,0.9 [0.72-1.13],0.36573059079681,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPOCK1,Testican-1,Inverse variance weighted,3,1.06 [0.94-1.19],0.365929250160448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,5,0.98 [0.93-1.03],0.368344786008536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,5,1.03 [0.97-1.1],0.368763374067889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,7,1.03 [0.96-1.11],0.369917192481547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,2,0.89 [0.69-1.15],0.369997225231505,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP8,Neutrophil collagenase,Inverse variance weighted,11,0.98 [0.94-1.02],0.371979244399693,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,10,1.02 [0.98-1.06],0.372527192773717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCRL5,Fc receptor-like protein 5,Inverse variance weighted,11,0.98 [0.94-1.02],0.374623946854115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GUCA2A,Guanylin,Inverse variance weighted,4,0.96 [0.86-1.06],0.374698361930958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGB6,Integrin beta-6,Inverse variance weighted,8,0.97 [0.92-1.03],0.375151466018339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLXNB2,Plexin-B2,Inverse variance weighted,13,0.99 [0.96-1.01],0.375806780128783,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADM,Pro-adrenomedullin,Wald ratio,1,1.09 [0.9-1.32],0.377608212531022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRH,Receptor-type tyrosine-protein phosphatase H,Inverse variance weighted,9,1.02 [0.98-1.06],0.377800230533341,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ROBO2,Roundabout homolog 2,Inverse variance weighted,3,1.11 [0.88-1.4],0.378844562722136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Inverse variance weighted,4,1.08 [0.91-1.27],0.378943972082448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,18,1.01 [0.98-1.05],0.379005986006379,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,3,1.15 [0.84-1.59],0.379254902298183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SEZ6L,Seizure 6-like protein,Inverse variance weighted,7,0.95 [0.85-1.06],0.382100555226217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,4,0.95 [0.84-1.07],0.382261900244516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,3,0.96 [0.87-1.06],0.38305237580954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPC5,Glypican-5,Inverse variance weighted,14,1.01 [0.98-1.05],0.383306362235459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,0.95 [0.85-1.06],0.386419782547487,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,11,0.97 [0.91-1.04],0.386692837339964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BOC,Brother of CDO,Inverse variance weighted,5,1.08 [0.91-1.27],0.388111591130181,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PALM2,Paralemmin-2,Inverse variance weighted,8,0.97 [0.89-1.05],0.388549172937934,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,18,1.02 [0.98-1.06],0.388774906109454,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,4,1.06 [0.93-1.21],0.389911967176283,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTHRC1,Collagen triple helix repeat-containing protein 1,Wald ratio,1,0.8 [0.47-1.34],0.391469916481879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ULBP2,UL16-binding protein 2,Inverse variance weighted,13,1.02 [0.98-1.06],0.394282074919443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1.08 [0.9-1.31],0.395154802106832,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNN,Tenascin-N,Inverse variance weighted,16,0.99 [0.95-1.02],0.395892804108091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,8,1.03 [0.97-1.09],0.39689763147874,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,9,1.03 [0.96-1.11],0.397623808498461,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AMBP,Protein AMBP,Inverse variance weighted,3,1.06 [0.92-1.23],0.398426009819184,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ECI2,Enoyl-CoA delta isomerase 2,Inverse variance weighted,4,0.97 [0.91-1.04],0.400449501649776,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CA14,Carbonic anhydrase 14,Inverse variance weighted,3,0.96 [0.86-1.06],0.402983699004842,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,8,0.98 [0.94-1.03],0.404110954885965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL18,C-C motif chemokine 18,Inverse variance weighted,5,0.92 [0.76-1.12],0.404203392607676,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSRC1,Proline/serine-rich coiled-coil protein 1,Inverse variance weighted,5,1.05 [0.93-1.18],0.405190608762352,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Wald ratio,1,1.1 [0.88-1.37],0.406137931800432,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",Inverse variance weighted,3,1.07 [0.91-1.25],0.406164896394634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCN1,Ficolin-1,Inverse variance weighted,9,0.97 [0.91-1.04],0.406908549232449,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,13,0.98 [0.94-1.02],0.408221293825374,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL19,Interleukin-19,Inverse variance weighted,7,0.97 [0.91-1.04],0.408385580532713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,10,0.98 [0.93-1.03],0.409014564978347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADH1B,All-trans-retinol dehydrogenase,Wald ratio,1,1.17 [0.8-1.71],0.409836962323588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,18,0.99 [0.95-1.02],0.412033613521631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL22,Interleukin-22,Wald ratio,1,0.84 [0.55-1.27],0.412059169783207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,12,1.03 [0.97-1.09],0.413659638193156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,13,1.02 [0.97-1.07],0.413883876183356,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,2,0.9 [0.69-1.17],0.420361163627771,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HRG,Histidine-rich glycoprotein,Inverse variance weighted,13,0.98 [0.93-1.03],0.420696122407735,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.93 [0.78-1.11],0.420712180333306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.95 [0.85-1.07],0.420895138276532,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,6,0.97 [0.9-1.05],0.420898488487567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPON2,Spondin-2,Inverse variance weighted,4,1.04 [0.95-1.14],0.422572485964383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CST6,Cystatin-M,Wald ratio,1,0.96 [0.87-1.06],0.422630316303417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCN1,CCN family member 1,Inverse variance weighted,2,0.93 [0.78-1.11],0.423492259499895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,3,0.89 [0.67-1.19],0.427134540469958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,22,1.01 [0.99-1.04],0.427236993447956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDHR5,Cadherin-related family member 5,Inverse variance weighted,15,0.99 [0.95-1.02],0.427792519811629,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SBSN,Suprabasin,Inverse variance weighted,9,1.03 [0.96-1.11],0.428126637642992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,1.07 [0.91-1.25],0.428397378206846,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,4,0.93 [0.77-1.12],0.42887890222408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,5,1.03 [0.96-1.1],0.43603928982978,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,12,1.02 [0.97-1.06],0.437429907514789,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,3,0.98 [0.93-1.03],0.439230209601399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,9,1.02 [0.97-1.08],0.440687253214086,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,5,1.05 [0.93-1.19],0.440808127626056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VWC2,Brorin,Inverse variance weighted,15,1.02 [0.97-1.06],0.440958698891741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL15,C-C motif chemokine 15,Inverse variance weighted,11,1.02 [0.98-1.06],0.441279648595796,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL10,Interleukin-10,Wald ratio,1,0.93 [0.77-1.12],0.443712695013522,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VWC2L,von Willebrand factor C domain-containing protein 2-like,Inverse variance weighted,2,0.93 [0.76-1.13],0.444226696208416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,STAB2,Stabilin-2,Inverse variance weighted,12,0.98 [0.95-1.03],0.446312938747433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDH17,Cadherin-17,Inverse variance weighted,7,1.02 [0.96-1.09],0.447868613223549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IFNGR2,Interferon gamma receptor 2,Inverse variance weighted,20,0.99 [0.97-1.01],0.448030039340627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCN5,CCN family member 5,Inverse variance weighted,3,0.94 [0.79-1.11],0.449380603012402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OMD,Osteomodulin,Wald ratio,1,0.86 [0.58-1.27],0.449651747654355,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HJV,Hemojuvelin,Wald ratio,1,1.05 [0.92-1.19],0.449992950314898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADIPOQ,Adiponectin,Inverse variance weighted,6,1.03 [0.95-1.13],0.450513731880733,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLK7,Kallikrein-7,Inverse variance weighted,4,0.95 [0.85-1.08],0.450673460105696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Wald ratio,1,0.94 [0.8-1.1],0.450729319686358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SEMA7A,Semaphorin-7A,Inverse variance weighted,4,1.15 [0.8-1.64],0.452007376279818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGMN,Legumain,Inverse variance weighted,9,0.97 [0.89-1.05],0.45239601160928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,6,1.06 [0.91-1.23],0.453009300762703,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,12,0.98 [0.92-1.04],0.455063294661302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAT,Linker for activation of T-cells family member 1,Wald ratio,1,1.19 [0.76-1.85],0.455483381278834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINA4,Kallistatin,Inverse variance weighted,8,1.02 [0.97-1.06],0.455934974523133,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLGN,Calmegin,Inverse variance weighted,14,0.99 [0.95-1.02],0.456966125800409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ARSB,Arylsulfatase B,Inverse variance weighted,7,0.98 [0.93-1.03],0.457502657015694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MOCS2,Molybdopterin synthase catalytic subunit,Inverse variance weighted,14,0.98 [0.93-1.03],0.45760091128157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,13,1.02 [0.97-1.08],0.45963806784691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DNMBP,Dynamin-binding protein,Inverse variance weighted,5,0.96 [0.86-1.07],0.463761930752672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,23,1.01 [0.98-1.04],0.465371165512495,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CBS,Cystathionine beta-synthase,Inverse variance weighted,2,0.96 [0.84-1.08],0.465813807978324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,4,1.02 [0.96-1.09],0.466944036349905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGB2,Integrin beta-2,Inverse variance weighted,3,1.07 [0.9-1.27],0.467116460322244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GAS2,Growth arrest-specific protein 2,Wald ratio,1,1.07 [0.89-1.28],0.468038000369115,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLG,Plasminogen,Inverse variance weighted,13,1.02 [0.96-1.09],0.468219395743947,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,4,0.98 [0.92-1.04],0.468877639027849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TEK,Angiopoietin-1 receptor,Inverse variance weighted,13,1.01 [0.98-1.05],0.471180557738245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,12,0.99 [0.95-1.03],0.471848800347696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MXRA8,Matrix remodeling-associated protein 8,Wald ratio,1,1.14 [0.8-1.61],0.471911635153424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,13,1.02 [0.97-1.08],0.472811210352072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,0.92 [0.74-1.15],0.475641883386186,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOD,Apolipoprotein D,Inverse variance weighted,4,0.97 [0.89-1.06],0.475990486683918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGAL,Integrin alpha-L,Wald ratio,1,0.9 [0.68-1.19],0.477265119437795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,11,0.98 [0.94-1.03],0.477491611794664,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BCAM,Basal cell adhesion molecule,Inverse variance weighted,7,1.03 [0.95-1.11],0.477894238931274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.06 [0.9-1.25],0.479673183799616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPY,Pro-neuropeptide Y,Wald ratio,1,0.85 [0.54-1.34],0.484009292414295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AMY2B,Alpha-amylase 2B,Inverse variance weighted,12,0.99 [0.95-1.02],0.485471708983007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANXA10,Annexin A10,Wald ratio,1,1.15 [0.78-1.68],0.485893558266081,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.11 [0.82-1.51],0.485989342728208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,REG1B,Lithostathine-1-beta,Inverse variance weighted,10,0.98 [0.93-1.04],0.487700225985439,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,REN,Renin,Inverse variance weighted,3,0.91 [0.69-1.19],0.487986056423108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FN1,Fibronectin,Inverse variance weighted,10,0.98 [0.94-1.03],0.488485450133676,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAT2,Linker for activation of T-cells family member 2,Wald ratio,1,1.18 [0.74-1.87],0.488517124940244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,6,1.02 [0.96-1.09],0.491202203113908,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,P4HB,Protein disulfide-isomerase,Inverse variance weighted,2,0.92 [0.72-1.17],0.491883917760481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CALCA,Calcitonin,Inverse variance weighted,3,0.91 [0.7-1.19],0.495636084715236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPVL,Probable serine carboxypeptidase CPVL,Inverse variance weighted,18,0.99 [0.96-1.02],0.496070979219711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,18,1.01 [0.98-1.05],0.498626765941217,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,7,0.97 [0.9-1.05],0.499641581549417,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRDX6,Peroxiredoxin-6,Inverse variance weighted,2,0.95 [0.81-1.11],0.499923099435101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,8,1.04 [0.93-1.16],0.50019803075659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ROBO1,Roundabout homolog 1,Inverse variance weighted,4,0.94 [0.78-1.13],0.500470186565876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,6,1.04 [0.93-1.15],0.501748974035643,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,3,1.05 [0.91-1.21],0.503054319105301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLITRK1,SLIT and NTRK-like protein 1,Wald ratio,1,1.06 [0.9-1.24],0.503789864259631,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGF23,Fibroblast growth factor 23,Wald ratio,1,0.94 [0.78-1.13],0.504813758682954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,6,0.98 [0.92-1.04],0.505096127090593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,12,0.98 [0.91-1.05],0.505199455053317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,3,0.97 [0.88-1.07],0.506091159513482,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,7,0.97 [0.9-1.06],0.506731923416347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BLMH,Bleomycin hydrolase,Inverse variance weighted,18,1.03 [0.94-1.12],0.507128513288913,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.96 [0.86-1.08],0.509804861454604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,4,0.95 [0.81-1.11],0.510093491457367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD300E,CMRF35-like molecule 2,Inverse variance weighted,7,1.02 [0.97-1.07],0.512581498431729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Wald ratio,1,1.09 [0.84-1.41],0.51364252039566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,5,1.02 [0.96-1.08],0.514146769225578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,2,1.05 [0.91-1.2],0.515500552615152,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,S100P,Protein S100-P,Wald ratio,1,1.12 [0.79-1.58],0.516435234868868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ESAM,Endothelial cell-selective adhesion molecule,Wald ratio,1,0.95 [0.83-1.1],0.51792434165009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,13,1.02 [0.96-1.08],0.518608947394925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD48,CD48 antigen,Inverse variance weighted,7,0.98 [0.93-1.04],0.518615806177078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CST7,Cystatin-F,Inverse variance weighted,25,0.99 [0.97-1.02],0.520365689490562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SHISA5,Protein shisa-5,Inverse variance weighted,3,1.04 [0.92-1.18],0.523072435367459,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WFDC2,WAP four-disulfide core domain protein 2,Wald ratio,1,1.09 [0.84-1.4],0.523749334901487,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL20,C-C motif chemokine 20,Wald ratio,1,0.93 [0.76-1.15],0.525387555647854,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSZ,Cathepsin Z,Wald ratio,1,0.85 [0.52-1.39],0.527145405767624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TP53I3,Quinone oxidoreductase PIG3,Inverse variance weighted,11,1.02 [0.95-1.1],0.528392332807628,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,9,0.98 [0.91-1.05],0.528661827403687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LPL,Lipoprotein lipase,Inverse variance weighted,8,0.98 [0.93-1.04],0.531291067276078,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,18,0.99 [0.96-1.02],0.532616079353501,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ABL1,Tyrosine-protein kinase ABL1,Wald ratio,1,1.15 [0.74-1.79],0.534656077979407,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,1.19 [0.69-2.06],0.53655043150693,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,0.97 [0.88-1.07],0.537336659361767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,5,1.02 [0.97-1.07],0.537377873855938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AGRN,Agrin,Inverse variance weighted,6,0.98 [0.91-1.05],0.538698795513451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINA12,Serpin A12,Inverse variance weighted,18,1.01 [0.98-1.03],0.539662056690488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,Inverse variance weighted,28,0.99 [0.97-1.01],0.542967014795499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGLC2,Immunoglobulin lambda constant 2,Wald ratio,1,0.93 [0.74-1.17],0.544090479678603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,9,1.01 [0.97-1.06],0.544897212633935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AMY2A,Pancreatic alpha-amylase,Inverse variance weighted,11,0.99 [0.95-1.03],0.545825555694898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ASAH2,Neutral ceramidase,Inverse variance weighted,23,0.99 [0.96-1.02],0.5465585623491,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL16,C-C motif chemokine 16,Inverse variance weighted,10,1.01 [0.97-1.06],0.546873239349148,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,2,1.13 [0.76-1.67],0.547651202897446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.98 [0.92-1.05],0.547822075366138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SNCG,Gamma-synuclein,Inverse variance weighted,13,0.98 [0.93-1.04],0.548087005633157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ALCAM,CD166 antigen,Inverse variance weighted,4,0.96 [0.85-1.09],0.548357279388165,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.1 [0.8-1.52],0.550098826910833,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DNPEP,Aspartyl aminopeptidase,Inverse variance weighted,2,0.95 [0.78-1.14],0.555323534458332,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.98 [0.91-1.05],0.556039385921255,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,15,1.01 [0.97-1.06],0.556182248267185,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NT5E,5'-nucleotidase,Inverse variance weighted,16,0.99 [0.95-1.03],0.556601341677642,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MAP2,Microtubule-associated protein 2,Inverse variance weighted,2,0.92 [0.71-1.2],0.556816248211388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,10,1.02 [0.95-1.1],0.559317210146433,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDA,Cytidine deaminase,Inverse variance weighted,14,0.99 [0.94-1.03],0.560360395978208,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.98 [0.92-1.05],0.565584396974773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HMCN2,Hemicentin-2,Inverse variance weighted,14,0.99 [0.96-1.02],0.565601422564428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHAD,Chondroadherin,Inverse variance weighted,2,0.88 [0.56-1.37],0.565747308021824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PKD1,Polycystin-1,Inverse variance weighted,5,1.03 [0.94-1.12],0.56723775427956,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CA6,Carbonic anhydrase 6,Inverse variance weighted,17,1.01 [0.97-1.06],0.569136103045548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CBLN4,Cerebellin-4,Inverse variance weighted,10,0.97 [0.88-1.07],0.569614198044013,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLK14,Kallikrein-14,Inverse variance weighted,11,0.98 [0.92-1.05],0.570982848609787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,4,0.97 [0.89-1.07],0.571922043520523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,S100A16,Protein S100-A16,Wald ratio,1,1.05 [0.88-1.27],0.572805022858154,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EFNA1,Ephrin-A1,Inverse variance weighted,8,0.98 [0.92-1.04],0.573773485265426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL3,C-C motif chemokine 3,Inverse variance weighted,6,1.02 [0.96-1.08],0.574533522957858,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,3,1.02 [0.96-1.07],0.574704876721999,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,6,1.02 [0.95-1.09],0.574996308338509,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGAM,Integrin alpha-M,Inverse variance weighted,2,0.95 [0.78-1.15],0.577724116001893,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,12,1.02 [0.96-1.08],0.579769285521178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,8,1.02 [0.95-1.09],0.579825597711947,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOA1,Apolipoprotein A-I,Wald ratio,1,0.87 [0.53-1.42],0.581761586618009,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLB1,"Phospholipase B1, membrane-associated",Inverse variance weighted,22,0.99 [0.96-1.02],0.58206013302468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.98 [0.92-1.05],0.583378908797203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NECTIN2,Nectin-2,Inverse variance weighted,3,0.93 [0.71-1.22],0.584640255976954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDKN1A,Cyclin-dependent kinase inhibitor 1,Wald ratio,1,0.89 [0.59-1.34],0.584895510123135,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,F11R,Junctional adhesion molecule A,Wald ratio,1,0.91 [0.65-1.27],0.585465219610349,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,7,1.02 [0.96-1.08],0.58855885736556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CES1,Liver carboxylesterase 1,Inverse variance weighted,5,1.03 [0.93-1.13],0.590208060113334,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGA11,Integrin alpha-11,Inverse variance weighted,6,0.98 [0.92-1.05],0.591050747578523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,13,0.99 [0.97-1.02],0.591123832622651,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SORT1,Sortilin,Inverse variance weighted,3,1.04 [0.9-1.21],0.591745094420226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,1.04 [0.89-1.22],0.592384136270059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,4,0.96 [0.82-1.12],0.592572667223445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PDGFC,Platelet-derived growth factor C,Inverse variance weighted,2,1.06 [0.86-1.3],0.593927801818907,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,12,0.98 [0.92-1.05],0.594589656723264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPL,N-acetylneuraminate lyase,Inverse variance weighted,4,1.02 [0.94-1.12],0.595467987520873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,8,1.01 [0.98-1.04],0.595522696612591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SOST,Sclerostin,Wald ratio,1,1.09 [0.79-1.51],0.596908187656041,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,6,1.04 [0.91-1.18],0.597352538445292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRC,Receptor-type tyrosine-protein phosphatase C,Inverse variance weighted,3,0.98 [0.89-1.07],0.597715756533888,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,4,0.97 [0.88-1.08],0.599566653232912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BAP18,Chromatin complexes subunit BAP18,Wald ratio,1,0.92 [0.67-1.26],0.600617007322593,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHGA,Chromogranin-A,Inverse variance weighted,3,1.04 [0.9-1.2],0.601396209814505,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,13,0.99 [0.94-1.04],0.601881032039747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,13,1.01 [0.96-1.07],0.602056455512969,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MENT,Protein MENT,Wald ratio,1,0.89 [0.58-1.37],0.60272544350359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PHLDB1,Pleckstrin homology-like domain family B member 1,Wald ratio,1,1.12 [0.72-1.74],0.604840225230131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,JAM3,Junctional adhesion molecule C,Inverse variance weighted,4,1.04 [0.9-1.2],0.605557982189623,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACAN,Aggrecan core protein,Inverse variance weighted,2,0.96 [0.82-1.13],0.608009449367195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,10,1.02 [0.95-1.1],0.608552482250182,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.93 [0.71-1.22],0.610195770866674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,REG1A,Lithostathine-1-alpha,Inverse variance weighted,8,1.02 [0.96-1.08],0.610535456306582,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TALDO1,Transaldolase,Wald ratio,1,0.9 [0.59-1.36],0.610743782281824,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.94 [0.74-1.2],0.610999125928839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,2,0.97 [0.87-1.09],0.611049374212091,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL14,C-C motif chemokine 14,Inverse variance weighted,9,0.98 [0.9-1.07],0.612982750318604,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,4,0.98 [0.93-1.05],0.613980332187472,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,3,1.06 [0.86-1.3],0.614356638776033,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,9,0.98 [0.92-1.05],0.614900369707878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,8,0.98 [0.93-1.05],0.615814778579493,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BGLAP,Osteocalcin,Wald ratio,1,0.96 [0.84-1.11],0.619410242888915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,4,1.03 [0.92-1.15],0.623788104357391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,21,1.01 [0.98-1.04],0.62451867743506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,12,1.02 [0.95-1.09],0.625378513056492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PARP1,Poly [ADP-ribose] polymerase 1,Wald ratio,1,0.96 [0.82-1.13],0.62574666319695,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGALS9,Galectin-9,Inverse variance weighted,12,0.98 [0.9-1.07],0.626418401338289,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OLFM4,Olfactomedin-4,Inverse variance weighted,19,0.99 [0.95-1.03],0.632325517575595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DLL1,Delta-like protein 1,Inverse variance weighted,3,0.96 [0.8-1.14],0.632397441291404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD27,CD27 antigen,Inverse variance weighted,8,1.02 [0.95-1.09],0.632859083770451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANGPTL2,Angiopoietin-related protein 2,Wald ratio,1,1.1 [0.75-1.61],0.633626347659476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,0.97 [0.87-1.09],0.634421855530882,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OGN,Mimecan,Inverse variance weighted,24,0.99 [0.96-1.03],0.634585727970821,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,5,1.03 [0.92-1.14],0.639213857249237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RBP7,Retinoid-binding protein 7,Inverse variance weighted,4,0.97 [0.83-1.12],0.639609987733949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGA5,Integrin alpha-5,Wald ratio,1,0.91 [0.62-1.35],0.640764992393409,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.02 [0.95-1.09],0.645113806887323,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAP3,Cytosol aminopeptidase,Inverse variance weighted,2,1.07 [0.79-1.46],0.64526982705099,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCRLB,Fc receptor-like B,Inverse variance weighted,16,0.99 [0.96-1.02],0.645662925914144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,5,1.02 [0.93-1.12],0.647927380361536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,7,1.01 [0.95-1.08],0.648665667044287,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLSCR3,Phospholipid scramblase 3,Wald ratio,1,0.93 [0.7-1.25],0.65047615982792,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCN2,Ficolin-2,Inverse variance weighted,13,1.01 [0.97-1.05],0.650768551433111,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LCP1,Plastin-2,Inverse variance weighted,7,0.99 [0.95-1.03],0.65110742300339,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,4,0.98 [0.9-1.07],0.654050043650982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COLEC12,Collectin-12,Inverse variance weighted,7,0.98 [0.88-1.08],0.65666413352603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL28,C-C motif chemokine 28,Wald ratio,1,0.93 [0.66-1.3],0.657258312564905,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C7,Complement component C7,Inverse variance weighted,15,0.99 [0.96-1.03],0.657571600870039,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPPC,C-type natriuretic peptide,Wald ratio,1,0.9 [0.57-1.43],0.658141249600024,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,7,0.99 [0.93-1.05],0.659322613984424,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,8,0.99 [0.95-1.03],0.659768273876574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MFGE8,Lactadherin,Inverse variance weighted,7,1.02 [0.92-1.14],0.659817345297506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TPK1,Thiamin pyrophosphokinase 1,Inverse variance weighted,8,1.01 [0.96-1.07],0.660971017887048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,2,0.95 [0.73-1.22],0.663143287268487,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PPL,Periplakin,Wald ratio,1,0.95 [0.76-1.19],0.663174838733937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNASE6,Ribonuclease K6,Inverse variance weighted,8,0.99 [0.95-1.03],0.667418660563702,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,6,1.02 [0.92-1.13],0.668819617129414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",Wald ratio,1,1.03 [0.9-1.18],0.668908136319685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,3,0.97 [0.82-1.13],0.670896655420559,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,7,1.01 [0.97-1.05],0.673148595731492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FOLR1,Folate receptor alpha,Inverse variance weighted,3,0.97 [0.84-1.12],0.674302594655496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TIMP3,Metalloproteinase inhibitor 3,Inverse variance weighted,14,0.99 [0.96-1.03],0.674444804759403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,3,1.02 [0.94-1.11],0.675925669894141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,POSTN,Periostin,Inverse variance weighted,6,1.03 [0.9-1.18],0.676494222871786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NRP1,Neuropilin-1,Inverse variance weighted,8,0.99 [0.92-1.05],0.676948159395533,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,7,1.02 [0.92-1.14],0.679303012654577,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP10,Stromelysin-2,Inverse variance weighted,10,1.01 [0.95-1.08],0.682025368439096,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,6,0.99 [0.94-1.04],0.682386516424746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,5,1.02 [0.93-1.12],0.684079583108259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.96 [0.78-1.18],0.68428088211169,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,9,0.99 [0.93-1.05],0.685187794976202,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSO,Cathepsin O,Inverse variance weighted,7,0.98 [0.88-1.09],0.685494781329782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,14,0.99 [0.93-1.05],0.686358674326386,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPM,Carboxypeptidase M,Inverse variance weighted,3,1.03 [0.91-1.16],0.688488309392388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,11,0.99 [0.93-1.05],0.688761445432568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,3,1.03 [0.89-1.2],0.690481114700058,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL17RA,Interleukin-17 receptor A,Inverse variance weighted,12,1.01 [0.98-1.03],0.692600148872436,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.97 [0.82-1.14],0.692634889200516,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGF5,Fibroblast growth factor 5,Inverse variance weighted,17,1.01 [0.97-1.05],0.692781522107317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,6,0.98 [0.9-1.07],0.694475638305892,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTBS,Di-N-acetylchitobiase,Inverse variance weighted,7,0.99 [0.95-1.03],0.69472774006786,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL21,C-C motif chemokine 21,Inverse variance weighted,2,1.04 [0.86-1.25],0.69587885464627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SDC4,Syndecan-4,Inverse variance weighted,6,1.04 [0.87-1.23],0.696195326112114,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,12,0.99 [0.95-1.03],0.696596059397203,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLAMF6,SLAM family member 6,Inverse variance weighted,2,1.02 [0.93-1.12],0.696643985151708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.06 [0.78-1.45],0.69665154149273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLIN3,Perilipin-3,Wald ratio,1,1.06 [0.78-1.44],0.698164333183819,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANXA5,Annexin A5,Wald ratio,1,0.97 [0.81-1.15],0.699409532732528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PVR,Poliovirus receptor,Inverse variance weighted,13,0.99 [0.96-1.03],0.699980006124741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.06 [0.78-1.46],0.701104525237092,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLB,Beta-klotho,Inverse variance weighted,21,1.01 [0.97-1.05],0.701541186676862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,6,0.98 [0.9-1.07],0.701572918331466,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLC16A1,Monocarboxylate transporter 1,Wald ratio,1,0.94 [0.69-1.29],0.701700947313881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,12,1.01 [0.97-1.05],0.702023243758895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNASET2,Ribonuclease T2,Inverse variance weighted,9,0.99 [0.94-1.04],0.702365277208743,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,8,1.01 [0.95-1.07],0.704522661043122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPARCL1,SPARC-like protein 1,Inverse variance weighted,15,1.01 [0.97-1.04],0.707165287919378,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,Inverse variance weighted,2,0.96 [0.79-1.18],0.707243600289161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.05 [0.83-1.32],0.707379653584665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SAT2,Thialysine N-epsilon-acetyltransferase,Inverse variance weighted,11,1.01 [0.97-1.04],0.707566122004218,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ARSA,Arylsulfatase A,Inverse variance weighted,11,1.01 [0.97-1.04],0.70812365296884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,10,1.01 [0.97-1.04],0.708387719171488,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GRN,Progranulin,Inverse variance weighted,4,1.02 [0.92-1.13],0.709045496836713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HEXIM1,Protein HEXIM1,Wald ratio,1,0.92 [0.61-1.4],0.709412018960632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,23,1 [0.98-1.03],0.714580532438817,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SELP,P-selectin,Inverse variance weighted,6,0.99 [0.93-1.05],0.71693011598691,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL1A1,Collagen alpha-1(I) chain,Wald ratio,1,1.08 [0.72-1.61],0.720123577308249,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD300C,CMRF35-like molecule 6,Wald ratio,1,1.02 [0.9-1.17],0.72053287935781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,14,1.01 [0.97-1.04],0.721970508044659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL7,C-C motif chemokine 7,Inverse variance weighted,2,0.95 [0.72-1.26],0.724171411945285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Wald ratio,1,1.03 [0.87-1.23],0.724346491204229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGF21,Fibroblast growth factor 21,Wald ratio,1,1.07 [0.74-1.55],0.726712113675273,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,19,0.99 [0.95-1.04],0.728378938630161,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BTN3A2,Butyrophilin subfamily 3 member A2,Wald ratio,1,1.01 [0.96-1.07],0.728429355345773,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APCS,Serum amyloid P-component,Inverse variance weighted,4,1.02 [0.93-1.11],0.730044975423464,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,2,0.98 [0.86-1.11],0.731445673585965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C3,Complement C3,Wald ratio,1,0.97 [0.82-1.15],0.731563620880278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LYPD8,Ly6/PLAUR domain-containing protein 8,Inverse variance weighted,6,1.01 [0.94-1.08],0.731957284367527,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,3,0.98 [0.89-1.09],0.734153432075279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL19,C-C motif chemokine 19,Inverse variance weighted,2,0.96 [0.76-1.21],0.739850777088567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRH,Corticoliberin,Inverse variance weighted,10,0.99 [0.93-1.05],0.740457141262584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADA2,Adenosine deaminase 2,Inverse variance weighted,3,1.01 [0.93-1.1],0.740615231842747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,0.93 [0.61-1.42],0.741818280235282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSC,Dipeptidyl peptidase 1,Inverse variance weighted,22,1 [0.97-1.02],0.74219460470369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PENK,Proenkephalin-A,Inverse variance weighted,11,0.99 [0.94-1.04],0.743978022285277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GLB1,Beta-galactosidase,Inverse variance weighted,3,1.01 [0.94-1.09],0.745866126873738,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,3,1.02 [0.9-1.16],0.746177300483907,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFF1,Trefoil factor 1,Inverse variance weighted,7,1.01 [0.93-1.11],0.746319099616426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,4,1.03 [0.86-1.24],0.748446544921811,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CA9,Carbonic anhydrase 9,Inverse variance weighted,2,1.02 [0.9-1.16],0.749026053463359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRISP2,Cysteine-rich secretory protein 2,Inverse variance weighted,17,1.01 [0.97-1.04],0.749458446695907,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,Inverse variance weighted,3,0.97 [0.8-1.18],0.750547018828098,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Wald ratio,1,1.06 [0.73-1.55],0.750992618699056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NECTIN4,Nectin-4,Inverse variance weighted,6,1.01 [0.95-1.07],0.753711288698668,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NUMB,Protein numb homolog,Inverse variance weighted,2,0.93 [0.57-1.49],0.75528219446734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,12,1.01 [0.96-1.06],0.755317749859637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,6,0.99 [0.91-1.07],0.755790905089928,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ATRN,"Attractin, Isoform 2",Inverse variance weighted,4,1.01 [0.95-1.08],0.755858306662443,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SDC1,Syndecan-1,Inverse variance weighted,3,0.98 [0.87-1.11],0.756500087658107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRTG,Protogenin,Inverse variance weighted,7,1.01 [0.96-1.06],0.757883660499611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,4,0.99 [0.9-1.08],0.75789359548069,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CNTN4,Contactin-4,Inverse variance weighted,16,0.99 [0.92-1.06],0.75918660667427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL18,Interleukin-18,Inverse variance weighted,9,0.97 [0.81-1.16],0.759484611927445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,4,1.01 [0.95-1.07],0.760851066873757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,2,1.02 [0.88-1.2],0.761636615496607,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAMB1,Laminin subunit beta-1,Inverse variance weighted,22,1.01 [0.96-1.05],0.762380208731914,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.04 [0.82-1.31],0.763111105525153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXCL8,Interleukin-8,Inverse variance weighted,4,1.02 [0.89-1.18],0.763417089004502,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOF,Apolipoprotein F,Wald ratio,1,0.94 [0.62-1.42],0.764119504088618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,8,1 [0.97-1.04],0.764293488363591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CNTN3,Contactin-3,Inverse variance weighted,8,0.99 [0.94-1.05],0.765113407551708,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MCAM,Cell surface glycoprotein MUC18,Wald ratio,1,0.98 [0.86-1.12],0.765448989556373,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,15,1.01 [0.96-1.06],0.766010112686549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDH2,Cadherin-2,Inverse variance weighted,3,1.02 [0.89-1.17],0.766260676294257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,F13B,Coagulation factor XIII B chain,Inverse variance weighted,17,1.01 [0.96-1.06],0.766543606586855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFRC,Transferrin receptor protein 1,Inverse variance weighted,18,0.99 [0.93-1.05],0.767364012415611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,7,0.97 [0.79-1.19],0.767791560527738,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,15,1.01 [0.97-1.04],0.769002305879275,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EDN1,Endothelin-1,Inverse variance weighted,3,0.99 [0.91-1.07],0.770104084842103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD276,CD276 antigen,Inverse variance weighted,14,0.99 [0.95-1.04],0.774023004779261,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FASLG,Tumor necrosis factor ligand superfamily member 6,Wald ratio,1,0.96 [0.74-1.26],0.77449209335861,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FST,Follistatin,Inverse variance weighted,4,0.98 [0.83-1.15],0.775159394597935,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.02 [0.91-1.13],0.775159654598302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SGSH,N-sulphoglucosamine sulphohydrolase,Inverse variance weighted,18,1 [0.97-1.02],0.775356611157528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CFHR4,Complement factor H-related protein 4,Inverse variance weighted,23,1 [0.98-1.02],0.779032070256187,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WIF1,Wnt inhibitory factor 1,Inverse variance weighted,2,0.99 [0.9-1.09],0.779226439284108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINA9,Serpin A9,Inverse variance weighted,16,1 [0.97-1.04],0.781756133081748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPQ,Carboxypeptidase Q,Inverse variance weighted,9,1.01 [0.94-1.09],0.78314061097657,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.95 [0.69-1.33],0.783278287527296,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,QDPR,Dihydropteridine reductase,Inverse variance weighted,2,1.03 [0.82-1.29],0.786108615081246,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PBLD,Phenazine biosynthesis-like domain-containing protein,Inverse variance weighted,10,1.01 [0.96-1.05],0.786147279384398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.07 [0.66-1.71],0.786343176638741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,14,1.01 [0.96-1.05],0.787150294935313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,THBD,Thrombomodulin,Inverse variance weighted,5,0.99 [0.9-1.09],0.787986588112746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.07 [0.66-1.72],0.788774546813145,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,2,0.98 [0.83-1.15],0.788792271741226,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP7,Matrilysin,Inverse variance weighted,9,1.01 [0.94-1.09],0.789258893334512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGALS3,Galectin-3,Inverse variance weighted,14,0.99 [0.93-1.05],0.790210861787333,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,2,0.96 [0.73-1.27],0.790360001440134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADA,Adenosine deaminase,Inverse variance weighted,15,0.99 [0.94-1.05],0.790540992297309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,12,0.99 [0.96-1.04],0.791678966070225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C9,Complement component C9,Inverse variance weighted,2,1.05 [0.73-1.51],0.795091570260102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IQGAP2,Ras GTPase-activating-like protein IQGAP2,Inverse variance weighted,2,0.98 [0.87-1.12],0.795735563068435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MPO,Myeloperoxidase,Inverse variance weighted,5,1.03 [0.82-1.29],0.797664960805564,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,7,0.99 [0.94-1.05],0.798493249581828,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FAM3B,Protein FAM3B,Inverse variance weighted,8,1 [0.97-1.04],0.798843030248729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NCS1,Neuronal calcium sensor 1,Wald ratio,1,0.98 [0.83-1.15],0.799925718699369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD7,T-cell antigen CD7,Inverse variance weighted,3,1.01 [0.96-1.05],0.800888643841678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHGB,Secretogranin-1,Inverse variance weighted,16,0.99 [0.94-1.05],0.800948152566578,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.01 [0.95-1.07],0.801280368810144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,5,1.01 [0.93-1.1],0.802673319635521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOL1,Apolipoprotein L1,Wald ratio,1,1.01 [0.94-1.09],0.803325388309353,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RASSF2,Ras association domain-containing protein 2,Inverse variance weighted,3,0.96 [0.71-1.3],0.806137859436158,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.02 [0.87-1.19],0.809988012796225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,4,1.02 [0.87-1.19],0.810564146184002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,4,1.02 [0.86-1.21],0.810584017629414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Inverse variance weighted,8,0.99 [0.94-1.05],0.810834997359492,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,7,0.99 [0.94-1.05],0.813596468886045,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,2,1.01 [0.91-1.13],0.814728649595521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FURIN,Furin,Wald ratio,1,1.01 [0.91-1.12],0.814865719224598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRF,Receptor-type tyrosine-protein phosphatase F,Inverse variance weighted,2,1.04 [0.75-1.43],0.81537896279689,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,10,1.01 [0.96-1.05],0.81619534013733,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.99 [0.9-1.09],0.816399033052494,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,11,1 [0.97-1.04],0.817260867770255,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MUC2,Mucin-2,Inverse variance weighted,4,1.01 [0.93-1.1],0.817815198278268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BMP6,Bone morphogenetic protein 6,Inverse variance weighted,3,1.03 [0.82-1.29],0.818101425446435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD22,B-cell receptor CD22,Inverse variance weighted,5,0.99 [0.9-1.08],0.819329052737931,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,11,0.99 [0.95-1.04],0.820511553369268,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.98 [0.82-1.17],0.820926965461712,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,11,0.99 [0.91-1.08],0.82561696236658,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WNT9A,Protein Wnt-9a,Inverse variance weighted,2,0.96 [0.67-1.38],0.827113455191427,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,Inverse variance weighted,5,0.99 [0.95-1.05],0.827326325508536,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DSCAM,Down syndrome cell adhesion molecule,Inverse variance weighted,9,0.99 [0.94-1.05],0.827399781777685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,6,1.01 [0.95-1.07],0.827931191378688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NIT2,Omega-amidase NIT2,Wald ratio,1,1.03 [0.8-1.33],0.830651007038826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD101,Immunoglobulin superfamily member 2,Inverse variance weighted,22,1 [0.97-1.04],0.831853719144307,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP1,Interstitial collagenase,Inverse variance weighted,20,1.01 [0.96-1.05],0.832848151192473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VNN1,Pantetheinase,Inverse variance weighted,20,1 [0.97-1.03],0.833682131315823,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LYPD3,Ly6/PLAUR domain-containing protein 3,Inverse variance weighted,10,1 [0.96-1.05],0.835460828640167,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OBP2B,Odorant-binding protein 2b,Inverse variance weighted,16,1.01 [0.95-1.06],0.835845731230715,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LONP1,"Lon protease homolog, mitochondrial",Inverse variance weighted,3,0.99 [0.87-1.12],0.837233582533237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BCAN,Brevican core protein,Wald ratio,1,1.04 [0.73-1.47],0.8373335163794,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MET,Hepatocyte growth factor receptor,Inverse variance weighted,5,0.97 [0.75-1.26],0.839165698343333,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,11,1 [0.97-1.04],0.840503529462403,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NTRK2,BDNF/NT-3 growth factors receptor,Inverse variance weighted,2,1.04 [0.7-1.56],0.840582464457909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DSC2,Desmocollin-2,Inverse variance weighted,4,1.01 [0.94-1.08],0.842774953886451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AGRP,Agouti-related protein,Wald ratio,1,1.05 [0.65-1.68],0.845354964686815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,11,1 [0.95-1.04],0.845420727435564,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,8,0.99 [0.93-1.06],0.845963549108281,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,1.02 [0.83-1.26],0.846280495507868,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RETN,Resistin,Inverse variance weighted,4,0.99 [0.93-1.06],0.846288539053125,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,Inverse variance weighted,2,1.04 [0.71-1.53],0.846445682369914,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.98 [0.83-1.17],0.84954526023278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,2,0.98 [0.81-1.2],0.850215259617878,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGA2,Integrin alpha-2,Inverse variance weighted,15,1 [0.97-1.03],0.850738365464474,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GIMAP7,GTPase IMAP family member 7,Inverse variance weighted,9,0.99 [0.93-1.07],0.854135721715529,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,Inverse variance weighted,6,0.99 [0.91-1.08],0.85439870297124,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CSTB,Cystatin-B,Inverse variance weighted,23,1 [0.97-1.04],0.857817203480818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,13,1 [0.96-1.04],0.859307906865369,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,5,0.99 [0.87-1.12],0.859660295256995,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPO,Erythropoietin,Wald ratio,1,1.02 [0.79-1.32],0.860782417004072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTN,Pleiotrophin,Inverse variance weighted,3,0.98 [0.82-1.18],0.862380797600734,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDH15,Cadherin-15,Inverse variance weighted,7,1.01 [0.92-1.11],0.864268314299376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPC1,Glypican-1,Inverse variance weighted,15,1 [0.95-1.05],0.864688596447396,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LSP1,Lymphocyte-specific protein 1,Inverse variance weighted,5,0.99 [0.87-1.12],0.865008097898487,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,12,0.99 [0.94-1.06],0.866875416203219,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD6,T-cell differentiation antigen CD6,Inverse variance weighted,24,1 [0.97-1.03],0.86697566041729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.01 [0.86-1.19],0.868071571955093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,1.01 [0.85-1.21],0.868071571955093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAMP1,Lysosome-associated membrane glycoprotein 1,Wald ratio,1,0.97 [0.69-1.37],0.86865039358094,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PYY,Peptide YY,Inverse variance weighted,3,0.99 [0.91-1.08],0.869769564084107,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCLY,Selenocysteine lyase,Inverse variance weighted,2,1.01 [0.92-1.11],0.869946545458391,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,3,0.99 [0.84-1.16],0.870186563569955,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLTP,Phospholipid transfer protein,Inverse variance weighted,10,1 [0.96-1.05],0.870348023666138,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGR,Tyrosine-protein kinase Fgr,Inverse variance weighted,2,0.99 [0.84-1.16],0.870984904118627,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,21,1 [0.97-1.04],0.872161160993171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,3,1.01 [0.87-1.18],0.872657127141082,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,1.05 [0.6-1.82],0.87323614722925,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,2,0.98 [0.79-1.22],0.873662937238713,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,3,1.02 [0.84-1.22],0.873773771949426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,3,1.01 [0.88-1.17],0.874767959892286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD160,CD160 antigen,Inverse variance weighted,5,0.99 [0.92-1.07],0.878026199922519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,5,1.01 [0.93-1.09],0.879769975638879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,14,1 [0.96-1.04],0.882141262711886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,14,1 [0.94-1.05],0.882223667746056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MILR1,Allergin-1,Inverse variance weighted,20,1 [0.96-1.05],0.882304411419197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BPIFB1,BPI fold-containing family B member 1,Inverse variance weighted,13,1 [0.96-1.05],0.887982731397815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CAPG,Macrophage-capping protein,Inverse variance weighted,15,1 [0.96-1.04],0.888794911444381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,Inverse variance weighted,11,1 [0.95-1.05],0.890816095004228,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,4,0.99 [0.88-1.12],0.892634515873843,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,7,0.99 [0.85-1.16],0.892901151832288,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,3,0.99 [0.88-1.12],0.89397631514469,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KITLG,Kit ligand,Wald ratio,1,0.98 [0.67-1.42],0.89481602436456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,9,1 [0.95-1.06],0.895037158660344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL17C,Interleukin-17C,Inverse variance weighted,3,1.01 [0.86-1.19],0.89539866415549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,12,1 [0.94-1.06],0.895649050811445,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AFP,Alpha-fetoprotein,Inverse variance weighted,5,0.99 [0.88-1.12],0.896470696196458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,Wald ratio,1,1.02 [0.76-1.37],0.89660052752829,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,21,1 [0.95-1.04],0.896632812320506,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,3,1 [0.93-1.06],0.898136484039245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DCXR,L-xylulose reductase,Wald ratio,1,1.02 [0.8-1.29],0.89878809869195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,4,1.01 [0.85-1.21],0.899287782645514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,6,1 [0.97-1.04],0.900492118273028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CSF2,Granulocyte-macrophage colony-stimulating factor,Inverse variance weighted,5,0.99 [0.87-1.13],0.901717307364142,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDHR2,Cadherin-related family member 2,Wald ratio,1,0.99 [0.82-1.19],0.903674489050934,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FAM3D,Protein FAM3D,Inverse variance weighted,8,1.01 [0.87-1.18],0.903997319334688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ESYT2,Extended synaptotagmin-2,Inverse variance weighted,3,0.99 [0.83-1.18],0.904261912365694,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLMAP,Sarcolemmal membrane-associated protein,Inverse variance weighted,2,0.99 [0.78-1.24],0.906275803090162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",Wald ratio,1,0.98 [0.65-1.47],0.907540951197812,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,7,0.99 [0.85-1.16],0.907844046827859,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXCL12,Stromal cell-derived factor 1,Inverse variance weighted,5,0.99 [0.89-1.11],0.910335640746153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,14,1 [0.96-1.05],0.911638100188564,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,XCL1,Lymphotactin,Inverse variance weighted,15,1 [0.97-1.03],0.911962531916723,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PEPD,Xaa-Pro dipeptidase,Inverse variance weighted,11,1 [0.94-1.06],0.912420622763147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,8,1 [0.94-1.06],0.912813350337566,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CREG1,Protein CREG1,Inverse variance weighted,2,0.99 [0.91-1.09],0.913978455319548,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPON1,Spondin-1,Inverse variance weighted,10,1 [0.93-1.08],0.915342047509528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CALB2,Calretinin,Wald ratio,1,1.02 [0.75-1.39],0.917321218226919,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ALDH1A1,Retinal dehydrogenase 1,Inverse variance weighted,2,1.01 [0.82-1.25],0.918468204247726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,8,1 [0.93-1.07],0.919847764952973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL16,Pro-interleukin-16,Inverse variance weighted,12,1 [0.96-1.04],0.924479017211481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD8A,T-cell surface glycoprotein CD8 alpha chain,Inverse variance weighted,5,1.01 [0.91-1.12],0.92461821832418,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PON2,Serum paraoxonase/arylesterase 2,Inverse variance weighted,27,1 [0.98-1.02],0.926609749012569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCG2,Secretogranin-2,Wald ratio,1,0.98 [0.64-1.51],0.926800335331747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,4,1 [0.91-1.11],0.92692581900023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHL1,Neural cell adhesion molecule L1-like protein,Inverse variance weighted,10,1 [0.95-1.06],0.928516437332949,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FOLR2,Folate receptor beta,Wald ratio,1,0.99 [0.83-1.19],0.929276988313926,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLK11,Kallikrein-11,Inverse variance weighted,2,1 [0.94-1.07],0.933079526914023,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INHBC,Inhibin beta C chain,Inverse variance weighted,13,1 [0.96-1.04],0.934470721340064,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCDH7,Protocadherin-7,Inverse variance weighted,2,0.99 [0.84-1.18],0.934926759192446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLEKHO1,Pleckstrin homology domain-containing family O member 1,Wald ratio,1,1.01 [0.73-1.4],0.935431963358358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,0.99 [0.76-1.3],0.942171302175129,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MASP1,Mannan-binding lectin serine protease 1,Inverse variance weighted,7,1 [0.92-1.08],0.94276122216964,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BTD,Biotinidase,Inverse variance weighted,10,1 [0.96-1.05],0.943691804497971,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,Inverse variance weighted,2,0.99 [0.78-1.26],0.944914276198389,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,1.01 [0.69-1.49],0.947121748548741,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,3,1 [0.92-1.09],0.949447002518211,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GALNT7,N-acetylgalactosaminyltransferase 7,Wald ratio,1,1.01 [0.76-1.34],0.950586380749859,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AP1G2,AP-1 complex subunit gamma-like 2,Inverse variance weighted,2,1 [0.88-1.15],0.952278806952615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,THBS2,Thrombospondin-2,Inverse variance weighted,12,1 [0.94-1.07],0.95242736666484,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGB7,Integrin beta-7,Wald ratio,1,0.99 [0.73-1.34],0.952480144961727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1 [0.87-1.14],0.95281209758518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LCAT,Phosphatidylcholine-sterol acyltransferase,Inverse variance weighted,2,1 [0.86-1.18],0.953678035378344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD36,Platelet glycoprotein 4,Inverse variance weighted,4,1 [0.94-1.07],0.953839725317589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,4,1 [0.85-1.19],0.954965588321144,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEP20,Centrosomal protein 20,Wald ratio,1,1.01 [0.83-1.22],0.956316363129821,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLUL1,Clusterin-like protein 1,Inverse variance weighted,13,1 [0.96-1.04],0.957385984370048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSB,Cathepsin B,Inverse variance weighted,13,1 [0.94-1.07],0.957962626036916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INSR,Insulin receptor,Wald ratio,1,0.99 [0.68-1.44],0.958896862546659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,2,0.99 [0.56-1.75],0.959195666655136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,3,1 [0.94-1.07],0.95988474777938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,F7,Coagulation factor VII,Inverse variance weighted,9,1 [0.94-1.06],0.960227432105367,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC1,Sialoadhesin,Inverse variance weighted,11,1 [0.96-1.04],0.961678967334855,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINH1,Serpin H1,Inverse variance weighted,3,1 [0.83-1.22],0.962335612536143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.99 [0.78-1.26],0.963556809711482,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1 [0.84-1.2],0.964180864639889,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,11,1 [0.94-1.06],0.964516249903434,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1 [0.92-1.09],0.966554967032408,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,3,1 [0.82-1.22],0.96778424854849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LPO,Lactoperoxidase,Inverse variance weighted,2,1 [0.93-1.07],0.968296069926927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ELOA,Elongin-A,Inverse variance weighted,2,1 [0.8-1.24],0.968641337117844,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,10,1 [0.92-1.08],0.96872379585514,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GLO1,Lactoylglutathione lyase,Inverse variance weighted,8,1 [0.93-1.07],0.969659827142768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL25,C-C motif chemokine 25,Inverse variance weighted,20,1 [0.96-1.04],0.970865181592449,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HYAL1,Hyaluronidase-1,Inverse variance weighted,4,1 [0.87-1.16],0.971547170369876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRG2,Bone marrow proteoglycan,Wald ratio,1,1 [0.82-1.21],0.973796094781805,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,3,1 [0.82-1.21],0.974503083657202,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,4,1 [0.86-1.16],0.974670564371201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KYNU,Kynureninase,Inverse variance weighted,6,1 [0.92-1.09],0.974713492714749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,6,1 [0.93-1.07],0.975604536254446,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,3,1 [0.82-1.22],0.976598413861143,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1 [0.93-1.07],0.976990458862097,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD79B,B-cell antigen receptor complex-associated protein beta chain,Wald ratio,1,1 [0.89-1.13],0.979746686490886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NAGK,N-acetyl-D-glucosamine kinase,Inverse variance weighted,2,1 [0.89-1.13],0.981048421233393,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EZR,Ezrin,Inverse variance weighted,2,1 [0.7-1.44],0.981568394877618,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,2,1 [0.71-1.4],0.981853585422614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,2,1 [0.68-1.49],0.982196986230421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,3,1 [0.95-1.06],0.982307300310704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD2AP,CD2-associated protein,Inverse variance weighted,5,1 [0.94-1.06],0.982857327942348,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,21,1 [0.97-1.03],0.98468271140632,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,8,1 [0.93-1.08],0.985804535695915,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSAP,Prosaposin,Inverse variance weighted,4,1 [0.92-1.09],0.986280918373674,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CR1,Complement receptor type 1,Inverse variance weighted,8,1 [0.92-1.09],0.986808795620666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1 [0.91-1.1],0.989413141344153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,1 [0.79-1.26],0.991576733824103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,15,1 [0.97-1.03],0.991994146672102,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GZMB,Granzyme B,Inverse variance weighted,4,1 [0.94-1.06],0.99249182703581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLK4,Kallikrein-4,Inverse variance weighted,8,1 [0.95-1.05],0.994252411112264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1 [0.81-1.23],0.996847061279031,cis
